Germany's BioNTech, CureVac joins coronavirus vaccine race
Germany’s Biotechnology giants BioNTech and CureVac joins the coronavirus vaccine race. They have passed the initial test and are currently carrying out human trials using new drugs.
Germany’s Biotechnology giants BioNTech and CureVac joins the coronavirus vaccine race. They have passed the initial test and are currently carrying out human trials using new drugs.